Bolno Paul's Form 4 filing
Wave Life Sciences, Inc. (WVE) · filed Nov 15, 2024
- Accession no.
- 0000950170-24-127740
- Filed
- Nov 15, 2024
- Trade date
- Nov 15, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $733.7K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bolno PaulCIK 0001657710 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2024 | Ordinary Shares | SSaleDisposed | −51,234 | $14.32 | −$733,670.88 | 217,351 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.